tirzepatide pregnancy safety guidance Use of GLP-1 drugs early in should not cause alarm, analysis suggests Tirzepatide (Zepbound) for weight loss

Ozempic targets only GLP-1

-Average weight loss of 20.7% at the 7.2mg dose at 72 weeks

The Diabesity Epidemic: Obesity contributes an estimated 85% toward the risk of type 2 diabetes, and obese individuals are about 7 times more likely to develop type-2 diabetes compared to those at a healthy weight

Moisture Sensitive Keep lyophilized vial sealed with desiccant until ready for reconstitution

Semaglutide and Tirzepatide reduce alcohol consumption in individuals with metabolic [PMID: 38017205] Laboratory literature summary: Semaglutide and Tirzepatide reduce alcohol consumption in individuals with metabolic research models

Asterisks indicate significant differences between doses of tirzepatide (mg per week injected subcutaneously).